🧬DeCurious.bio/acc

Curious about DESCI and a beleiver in the scientific singularity.
Degen on the Desci side via @pumpdotscience.
Bullish on $BIO and Bio-protocol.
$LAB

[🧬DeCurious.bio/acc @YDecurious]

Calling all AI devs and researchers! 🤖🔬: Bio-protocol is on the hunt for talented individuals like you to join the community!. 📢

How to join:Just Shoot @AakaashMeduri, @alxdobrin
a DM)
Mention my handle @YDecurious as your referee when you sign up.

See on the side that wins

[🧬DeCurious.bio/acc @YDecurious]

@questmoosa Try MINX of @anagenxyz

[🧬DeCurious.bio/acc @YDecurious]

@oxidativestate Try MINX of @anagenxyz

[🧬DeCurious.bio/acc @YDecurious]

@JuanchoMxx Check out @anagenxyz , they are not just concerned with quick fixes for hair regeneration but the Mission is to FIND THE CURE!!...

By going the DESCI- route, funding R&D via an On-chain pipeline.

$LAB is the ticker!

[DeSci Atoms @desciatoms]

⚛️DeSci Atoms Market Update 6 June 2026
MarketCap 24hrs Top Gainers
1. Wrapped DNX ($0xDNX) +3.72% @dynexcoin
2. Galeon ($GALEON) +3.63% @GaleonCare

Overall DeSci Atoms Marketcap
Total Market Cap: $530,671,483.77 -7.23%
Total 24hrs Volume: $553,312.42 -41.61%

[ResearchHub Foundation @ResearchHubF]

ResearchCoin ($RSC) is now officially listed and available for trading on @Revolut.

This puts $RSC in front of 70M+ users across one of Europe’s largest financial platforms.

With Revolut now operating as a licensed bank in the UK, buying and accessing $RSC through a regulated platform available across Europe has become easier.

[🧬DeCurious.bio/acc @YDecurious]

The current commercial expansion at @anagenxyz .xyz, specifically the launch of the MINX oral minoxidil line and the Precision Dutasteride platform, acts as a primary catalyst for the HairDAO Laboratory ($LAB) token and the broader HairDAO ecosystem.

As the decentralized science (DeSci) research network behind these treatments, the commercial success of @anagenxyz .xyz directly drives the value and utility of the ecosystem in several key ways:

1)Intellectual Property (IP) Value Accrual: @HairDAO_ operates by identifying, funding, and minting early-stage hair loss treatments as IP-NFTs (Intellectual Property Non-Fungible Tokens). Because @anagenxyz .xyz serves as the primary commercialization vehicle for this research, product launches like MINX and Precision Dutasteride demonstrate that the DAO can successfully move treatments from open-source laboratory R&D to a revenue-generating telehealth consumer market.

2)Validation of the BioDAO Flywheel: In traditional biotech, drug development is siloed. The launch of MINX validates HairDAO’s "patient-centric BioDAO" playbook. Successful market adoption generates real-world data and commercial interest, which increases the perceived market value of the $LAB governance token as the steering mechanism for future clinical formulations and pipeline decisions.

3)Tokenomics and Ecosystem Roles: Within the network, the decentralized framework is split between $HAIR (the main Ethereum-based ecosystem governance token used to vote on high-level funding allocations) and $LAB (the Solana-based token intimately tied to HairDAO Laboratory operations and distribution initiatives). As commercial products scale, the laboratory token benefits from heightened on-chain transactions, utility incentives, and data-logging protocols as patients input their treatment experiences.

We will find the cure to Hairloss!
$LAB is the ticker
LFG🔥💪

[verbinnen.eth💈 @VerbinnenAndrew]

MINX now has options !

Three doses: 5mg, 2.5mg, 1.25mg

[BioAIDevs @BioAIDevs]

A research session is more useful when others can see it.

BIOS research sessions are now shareable via public link so collaborators can access the full investigation, not just a summary.

Try it at https://t.co/i5ZqZy5jw3

[DeSci.Berlin @DeSciBerlin]

Michael @Mykalt45 just sold CrossBridge Bio to Eli Lilly for up to $300M.

Now he's leading ARTANBio ($VITARNA), a @vitadao-backed gene therapy program going after premature termination codons in aging.

At DeSci Berlin, he'll walk through what changes when biotech funding captures upside earlier.

[Anagen💈 @anagenxyz]

MINX MINI and MINX LITE are now live.

A lot of people want to try oral minoxidil.

They just don’t want to start at 5 mg.

So we built lower-dose versions:

MINX MINI 1.25 mg
MINX LITE 2.5 mg

Same MINX delivery vehicle.

Start smaller.

MINX MINI → https://t.co/tEA5Jbj0KA

MINX LITE → https://t.co/UX5kmC8Jan

[DeSci Atoms @desciatoms]

⚛️DeSci Atoms Market Update 5 June 2026
MarketCap 24hrs Top Gainers
1. Peptome ( $PEPT ) +12.99% @peptome_ai
2. Peptai ( $PEPTAI ) +11.80% @peptai_
3. Data Lake Token ( $LAKE ) +10.20%

Overall DeSci Atoms Marketcap
Total Market Cap: $572,030,923.77 -8.68%
Total 24hrs Volume: $947,548.14 +41.29%

[Bio Protocol @BioProtocol]

AI is changing what a single scientist can do.

Models can predict protein structures, propose experiments, and read literature at a scale no human can match.

The bottleneck is shifting from "can we run the experiment" to "who funds and coordinates all of it."

[🧬DeCurious.bio/acc @YDecurious]

Delusional optimism is the way out!.
Stay Dogged🔒

[🧬DeCurious.bio/acc @YDecurious]

Looking for Evidence based information on hair loss l, then get started @anagenxyz .

[Anagen💈 @anagenxyz]

Can an internet anon cure hair loss?

We are testing TWIST1, a transcription factor linked to dermal papilla biology, androgenetic alopecia datasets, fibrosis, and hair-cycle regulation.

The hypothesis took @hairypapasmurf around five years to develop.

We just completed the first gating experiment. Before screening the TWIST1 inhibiting molecules, we needed to know the target is actually measurable.

Not all cells express TWIST1.

Our BT-549 screening line passed.

TWIST1 came in at Cq 21.30–21.91 across baseline samples.

That is far below our internal Cq ~30 adequacy line, meaning there is enough baseline transcript to measure real knockdown.

The true TWIST1 signal also sat ~14–16 cycles ahead of background controls.

This does not prove hair growth. It does not prove safety. It does not mean TWIST1 is ready for patients.

But it means the program is now assay-ready.

The next step is ASO screening.

Can we reliably knock down TWIST1, and does that shift hair-relevant biology in the right direction?

Full report here → https://t.co/Cum74rSosc

[🧬DeCurious.bio/acc @YDecurious]

@anagenxyz @hairypapasmurf Evidence based information on hair loss!.

Fucking with @anagenxyz every single fucking day.

LFG 🔥💪

[WIRED @WIRED]

With $500 million in funding and a reported $2.5 billion valuation, Flourish wants to reinvent AI by putting real neurons under the microscope. https://t.co/NaPKCRprkW

[🧬DeCurious.bio/acc @YDecurious]

If you bought $HYPE that's your Bullrun!.

Watching $ICP NEXT🔥🔥
ATH will blow your minds!

[🧬DeCurious.bio/acc @YDecurious]

It turned out to be that the $HYPE is REAL!!!.

[🧬DeCurious.bio/acc @YDecurious]

It turned out to be that the $HYPE is REAL!!!.

[Anton @seahorse_anton]

The TechBio Revolution by $ABCL and $RXRX Deep dive

[Kyle LaHucik @ky_lahucik]

Dimension Capital eyes up to $750M for its 3rd fund

NYC + SF firm invests at intersection of computation+science

Portcos: Chai Discovery, NewLimit, Earendil Labs, Odyssey Therapeutics, Enveda + others

$350M debut in '23
$500M sophomore fund in '24

https://t.co/k7anLHgZzp